Figure 1
From: Patient-reported sexual toxicity after radiation therapy in long-term prostate cancer survivors
The effect of age on symptom prevalence for prostate cancer survivors displayed by radiation therapy regimen. Ages younger than 60 years, between 60 and 70 years, and above 70 years displayed on the x axis and symptom prevalence on the y axis. Primary external beam radiation therapy (EBRT) displayed in the dark grey bars, EBRT in combination with brachytherapy (EBRT+BT) displayed in the light grey bars, and salvage EBRT displayed in the white bars; the dotted line is the symptom prevalence in reference men younger than 60 years, the light grey line in reference men 60–70 years, and the dark grey line in reference men older than 70 years. The number preceding the symptom refers to the associated question number in Table 2.
